Alzheimer’s Drug In Development, Lecanemab, May Benefit Some Patients But Carries Risks of Brain Swelling and Bleeding nytimes.com Submitted by Relevant_synapse t3_z8ez5o on November 30, 2022 at 2:51 AM in science 90 comments 923
[deleted] t1_iycx7f3 wrote on November 30, 2022 at 1:55 PM Reply to comment by Gummibando in Alzheimer’s Drug In Development, Lecanemab, May Benefit Some Patients But Carries Risks of Brain Swelling and Bleeding by Relevant_synapse [removed] Permalink Parent 1 [deleted] t1_iycxsq0 wrote on November 30, 2022 at 2:00 PM [removed] Permalink Parent 1
Viewing a single comment thread. View all comments